Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT06655155 ×

NCT06655155

This funder is selected. Its supporting articles are shown below.

NCT066551551

Articles mentioning NCT06655155

1 articles · page 1 of 1

P.272 Efgartigimod PH20 subcutaneous in adults with systemic sclerosis: a phase 2, randomized, double-blinded, placebo-controlled, parallel-group study (eSScape

jsrd · abstract · 2026-06-05 · 1 matching annotations

85.8%

NCT06655155 Health Assessment Questionnaire efgartigimod Systemic Sclerosis Systemic sclerosis (SSc)recombinant human hyaluronidase PH20 rHuPH20 interstitial lung disease pulmonary arterial hypertension

… in several IgG-driven autoimmune diseases. The eSScape study ( NCT06655155) aims to establish proof-of-concept of efgartigimod PH20 SC in …